WASHINGTON, DC - Today, Congressman Rodney Frelinghuysen (NJ-11) led a visit to the National Institutes of Health (NIH) with members of the national Alzheimer’s Association. He was accompanied by a number of New Jersey residents, including, Robyn Kohn-Tenner of Wayne and Randy Lerner of Livingston.

The group had the opportunity to visit the world class research facilities in Bethesda, MD and meet face to face with the individuals leading the cutting edge Alzheimer’s research including Dr. Richard Hodes, Director of the National Institute on Aging, and Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke and those conducting clinical trials and genetic research.

“Today’s visit allowed New Jersey families, who face the challenges of Alzheimer’s, to share their stories with the experts at the NIH and see, firsthand, their groundbreaking work. With 5 million people suffering from Alzheimer’s, it is vital that the NIH continues this research to find treatments, and ultimately a cure for this disease which has devastated so many families. As a member of the Congressional Task Force on Alzheimer’s Disease, I have long been a proponent of funding for Alzheimer’s research conducted at the NIH,” said Frelinghuysen.

This week, the House of Representatives is slated to consider the Conference Report to H.R. 6157 , the Department of Defense, and the Labor, Health and Human Services Appropriations bill for Fiscal Year (FY) 2019, introduced by Congressman Frelinghuysen, Chairman of the House Committee on Appropriations. This legislation includes $2.3 billion for Alzheimer’s disease research at the NIH, which is an increase of $425 million above FY18 and builds upon the $400 million increase included in FY18.

(Congressman Rodney Frelinghuysen with New Jersey members of the Alzheimer’s Association, Dr. Richard Hodes, Director of the National Institute on Aging, and Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke)

#####